PUBLICATIONS

Dr. Smith, as a member of the BrainSeq Consortium, has contributed to two high-impact publications over the past year. The first examines the neuroimmunogenic architecture of schizophrenia, while the second examines the developmental and genetic regulation of the human cortex transcriptome in schizophrenia.

Influence of Serotonin Transporter SLC6A4 Genotype on the Effect of Psychosocial Stress on Cognitive Performance: An Exploratory Pilot Study

Smith, R.M. (2017). Advancing psychiatric pharmacogenomics using drug development paradigms. Pharmacogenomics. Published Online October 4th, 2017.

Ruble, C.L., Smith, R.M., Calley, J., et al. (2016). Genomic structure and expression of the human serotonin 2A receptor gene (HTR2A) locus: identification of novel HTR2A and antisense (HTR2A-AS1) exons. BMC Genet, 17, 16. PMCID: PMC4702415

Ramsay, J.E., Rhodes, C.H., Thirtamara-Rajamani, K., et al. (2015). Genetic influences on nicotinic α5 receptor (CHRNA5) CpG methylation and mRNA expression in brain and adipose tissue. Genes and Environ, 37, 14. PMCID: PMC4917931

Smith, R.M., Banks, W., Hansen, E., Sadee, W., & Herman, G.E. (2014). Family-Based Clinical Associations and Functional Characterization of the Serotonin 2A Receptor Gene (HTR2A) in Autism Spectrum Disorder. Autism Res, 7, 459-467. PMCID: PMC4134733

Smith, R.M., Webb, A., Papp, A.C., Newman, L.C., Handelman, S.K., Suhy, A., Mascarenhas, R., Oberdick, J., & Sadee, W. (2013). Whole transcriptome RNA-Seq allelic expression in human brain. BMC Genomics, 14, 571. PMCID: PMC3765493

Smith, R.M., Papp, A.C., Webb, A., Ruble, C.L., Munsie, L.M., Nisenbaum, L.K., Kleinman, J.E., Lipska, B.K., & Sadee, W. (2013). Multiple regulatory variants modulate expression of 5-hydroxytryptamine 2A receptors in human cortex. Biol Psychiatry, 73, 546-554. PMCID: PMC3582836